Your weight loss journey begins today
The BPC-157 group in this study held their gains through the 12-month mark without retreatment
The oncogenic miRNAs of the miR-17-92 cluster suppress negative regulators of phosphatidylinositol-3-OH kinase signaling or pro-apoptotic members of the BCL-2 family, which disrupts the processes known to influence cancer development
Melanoma Risk The relationship between MT-2 and melanoma is not definitively established, but the theoretical concern is significant: MT-2 stimulates melanocyte proliferation the same cell type that becomes malignant in melanoma At least 4 case reports link MT-2 use to melanoma diagnosis (Hjuler et al., 2014) No long-term safety data exists MT-2 has never completed Phase III trials for tanning However, it's important to note: Case reports cannot establish causation MT-2 users are often the same population that uses tanning beds (an established melanoma risk factor) The FDA-approved MT-1 (afamelanotide), which works through the same MC1R pathway, has not shown melanoma signals in clinical trials Bottom line: The risk is theoretical but plausible
Several variants in the TRPM3 gene are more often found in people with ME/CFS.[ref] NLRP3 inflammasome activation and fatigue: Another innate immune system component, the NLRP3 inflammasome, is also implicated in fatigue syndromes, including ME/CFS and MS.[ref][ref] NLRP3 is a linchpin at the start of the immune cascade
Can You Use Them Together
